Loading
Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Pitman · consortium | United States | none recorded | 1 | not matched | - | none recorded | - |
Hinxton · research institute | United Kingdom | none recorded | 0 | 97 | 1,204 | - | |
Brussels · consortium | Belgium | none recorded | 0 | 7 | 76 | none recorded | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Langerhans cell histiocytosis but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.
31 centres are named on one of the types below rather than on Langerhans cell histiocytosis (LCH) itself. Grouped by the type that holds them; the full table for each sits on that type's page.